
Results
269
Most Popular Stocks on the market
269 companies
Samsung BiologicsLtd
Market Cap: ₩71.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,549,000.00
7D
3.9%
1Y
-3.1%
Celltrion
Market Cap: ₩46.3t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩202,000.00
7D
6.1%
1Y
20.5%
ALTEOGEN
Market Cap: ₩22.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩317,500.00
7D
14.6%
1Y
-8.1%
Samsung Epis Holdings
Market Cap: ₩10.1t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩407,500.00
7D
4.8%
1Y
n/a
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩88,200.00
7D
7.6%
1Y
-12.0%
Yuhan
Market Cap: ₩6.2t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩83,100.00
7D
10.7%
1Y
-26.7%
Hanmi Pharm
Market Cap: ₩5.0t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩396,000.00
7D
4.2%
1Y
40.7%
ABL Bio
Market Cap: ₩4.9t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩86,800.00
7D
8.2%
1Y
6.4%
Sam Chun Dang Pharm
Market Cap: ₩4.4t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩186,200.00
7D
11.8%
1Y
0.05%
Peptron
Market Cap: ₩4.3t
Engages in the development of peptide-based medicines.
A087010
₩186,400.00
7D
8.7%
1Y
-46.6%
LigaChem Biosciences
Market Cap: ₩4.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩115,100.00
7D
5.1%
1Y
-26.1%
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩408,000.00
7D
7.9%
1Y
-38.6%
Voronoi
Market Cap: ₩3.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩174,900.00
7D
18.6%
1Y
43.1%
Caregen
Market Cap: ₩3.1t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩64,400.00
7D
1.3%
1Y
30.2%
Hugel
Market Cap: ₩2.9t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩268,500.00
7D
3.3%
1Y
-15.6%
SK bioscienceLtd
Market Cap: ₩2.9t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩36,500.00
7D
5.5%
1Y
-20.6%
Hanall Biopharma
Market Cap: ₩2.8t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩55,700.00
7D
4.9%
1Y
90.8%
D&D Pharmatech
Market Cap: ₩2.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩60,500.00
7D
13.9%
1Y
69.8%
OliX Pharmaceuticals
Market Cap: ₩2.4t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩113,500.00
7D
-6.6%
1Y
106.7%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,000.00
7D
6.2%
1Y
14.2%
Celltrion Pharm
Market Cap: ₩2.0t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩44,450.00
7D
5.8%
1Y
-14.6%
Mezzion PharmaLtd
Market Cap: ₩1.9t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩63,200.00
7D
11.1%
1Y
71.3%
Kolon TissueGene
Market Cap: ₩1.8t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩21,350.00
7D
14.4%
1Y
-44.5%
Aimed Bio
Market Cap: ₩1.8t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩27,450.00
7D
13.0%
1Y
n/a
L&C BIOLTD
Market Cap: ₩1.5t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩56,800.00
7D
-1.7%
1Y
80.3%
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩23,050.00
7D
4.1%
1Y
7.5%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,800.00
7D
15.5%
1Y
15.0%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩129,500.00
7D
5.9%
1Y
-4.4%
Seegene
Market Cap: ₩1.5t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩31,950.00
7D
13.9%
1Y
13.9%
JS Link
Market Cap: ₩1.4t
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩41,600.00
7D
17.7%
1Y
148.5%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,800.00
7D
0.2%
1Y
-5.5%
Orum Therapeutics
Market Cap: ₩1.4t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩65,900.00
7D
11.7%
1Y
164.7%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩41,650.00
7D
2.8%
1Y
-5.8%
DongKook Pharmaceutical
Market Cap: ₩974.4b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩21,600.00
7D
17.9%
1Y
22.7%
Qurient
Market Cap: ₩973.9b
A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.
A115180
₩23,950.00
7D
10.9%
1Y
115.8%
Rznomics
Market Cap: ₩937.7b
Develops RNA based gene therapies for cancers and intractable diseases.
A476830
₩33,650.00
7D
5.2%
1Y
n/a